Screener
Charles River Laboratories CRL Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Charles River Laboratories in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 9:21 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001100682-26-000118
| Line item | June 27, 2026 | December 27, 2025 |
|---|---|---|
| Intangible assets, net | 253,174 | 339,995 |
| Deferred tax assets | 53,827 | 67,334 |
| Other assets | 587,556 | 293,185 |
| Total assets | $7,532,145 | $7,135,422 |
| Liabilities, Redeemable Noncontrolling Interests and Equity | ||
| Current liabilities: | ||
| Accounts payable | $140,983 | $148,800 |
| Accrued compensation | 187,835 | 268,854 |
Item 1. Financial Statements
FAQ
- What is Charles River Laboratories's total assets?
- Charles River Laboratories (CRL) reported total assets of $7.53B in Q2 2026.
- How has Charles River Laboratories's total assets changed year-over-year?
- Charles River Laboratories's total assets decreased by 0.4% year-over-year, from $7.56B to $7.53B.
- What is the long-term trend for Charles River Laboratories's total assets?
- Over 5 years (2020 to 2025), Charles River Laboratories's total assets has grown at a 5.4% compound annual growth rate (CAGR), from $5.49B to $7.14B.
- What does total assets mean?
- The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.
Ask your AI about Charles River Laboratories's total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude